DOCSLIB.ORG

Curriculum Vitae

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Curriculum Vitae CURRICULUM VITAE NAME Morris Mosseri, ID: 6076975-9 Associate Professor in Medicine, Cardiology (Tel-Aviv University) FACULTY/DEPT Tel-Aviv University, Sackler Medical School, Cardiology HOSPITAL/DEPT Meir Medical Center, Cardiology Tel: (972) 9-7472587 HOME ADDRESS 1 Streichman St. Tel-Aviv 69671 Tel: (972) -3-7415094 DATE AND PLACE OF BIRTH: December 3, 1951, Egypt DATE OF ARRIVAL IN April, 1957 ISRAEL ZAHAL (ISRAELI) May 1, 1977 April 30, 1982 MILITARY SERVICE (Enlisted Discharged) MARITAL STATUS Married NO. OF CHILDREN 3 children A. Education PERIOD OF STUDY 1969-1975 Medical School of the Hebrew University and Hadassah, Jerusalem, Israel. MD degree. Professional Licensure and Certifications: 1976 Board of Registration in Medicine, Israel 1976 ECFMG Certificate 1983 VQE Certificate 1987 Board Certificate in Cardiology (Israel) 1991 Board of Registration in Medicine, Boston MA 2006 European Cardiologist Diploma Name: Morris Mosseri Degree: MD CV: updated 1.2.2012 Title of Doctoral "Evaluation of the examinations performed with the Dissertation: computerized echoencephalography in 2,000 patients". Name of Supervisor Prof. Herishanu, Hadassah Medical Center B. FURTHER STUDIES Period of Study 1981-1984 Resident and senior resident, Internal (dates) Medicine Department, Hadassah University Hospital, Mt. Scopus, Jerusalem, Israel. 1984-1986 Fellow, Cardiology Department, Hadassah University Hospital, Ein-Kerem Jerusalem, Israel. 8/1988 Fellow in the 21st International Teaching Seminar on Cardiovascular Epidemiology and Prevention, The Netherlands (International Society and Federation of Cardiology/ The World Health Organization). 2 Name: Morris Mosseri Degree: MD CV: updated 1.2.2012 C. ACADEMIC AND PROFESSIONAL EXPERIENCE (FOR MDs – ACADEMIC EXPERIENCE; CLINICAL EXPERIENCE) TEACHING ACADEMIC APPOINTMENTS: 3/82 Instructor in Internal Medicine, Hadassah University Medical School, Jerusalem, Israel 3/86 Lecturer in Internal Medicine, Hadassah University Medical School, Jerusalem, Israel. 2/90 - 6/92 Assistant Professor in Medicine, Tufts University Medical School, Boston, MA. U.S.A. 2/92 Senior Lecturer in Internal Medicine (Cardiology), Hadassah Hebrew University Medical School, Jerusalem, Israel. 3/99-5/2007 Associate Professor in Medicine (Cardiology), Hadassah University Medical School, Jerusalem, Israel. Since 1/1/2009 Associate Professor in Medicine (Cardiology), Tel- Aviv University, Sackler Medical School, Tel-Aviv, Israel. PROFESSIONAL APPOINTMENTS: 1987-2006 Staff Senior Cardiologist, Cardiology Department, Hadassah University Hospital, Ein-Kerem, Jerusalem, Israel. 1987-2000 Co-Director of Catheterization and Inpatient Cardiology Units. Hadassah University Hospital, Ein-Kerem Jerusalem, Israel. 8/1989-8/1991 Research Associate, Department of Medicine, Division of Cardiology, St. Elizabeth's Hospital, Boston, MA. 1998 Research Associate, Cardiovascular Research Foundation, Cardiology Department, Washington Hospital Center, Washington DC., U.S.A. 2000-2003 Head of the Internal Medicine Section, Hebrew University and Hadassah Medical School, Jerusalem, Israel. 1/2000-11/2006 Director of Interventional Cardiology, Hadassah Hebrew University Medical center, Jerusalem Israel. Deputy Head of the Heart Institute, Hadassah Hebrew University Medical center, Jerusalem Israel. 11/05-11/06 Director of the Excellence Center for Vascular Diseases, Hadassah Hebrew University Medical center, Jerusalem Israel. Since 1.11.2006 Head of Cardiology Division, Meir Medical Center, Kfar-Saba, Israel. 3 Name: Morris Mosseri Degree: MD CV: updated 1.2.2012 ADDITIONAL ACADEMIC AND PROFESSIONAL APPOINTMENTS 1987-1989, and 1992-1995 Director of Cardiology Courses for 6th Year Medical Students, Hadassah Hebrew University Medical School 1995 Member, Guidelines for Treatment of Post MI Patients in the Community Committee 1997 Member, Steering Committee of the ICDC - Cardiovascular Diseases, Ministry of Health, Israel 1992-2003 Member, Medical Students Admitting Committee, Hebrew-University Hadassah Medical School 1995-1997 Deputy-Editor of Cardiology Update Journal. 1993-2000 Member, Graduating Examinations Committee, Hebrew-University Hadassah Medical School 1997-2003 Editor, The Journal of Israel Heart Society 1999-2003 Chair, Radiation Committee, Interventional Cardiology, The Israel Heart Society. 2001-2003 Chair, Committee for Technology advancement, Hadassah Medical Center, Jerusalem Since 2003 Member, The National Council for Diabetes Mellitus 2004-2006 Director of Phase II Cardiology Board Examinations 2005-2006 Member of the Committee for Academic Exchange Programs, Hadassah Hebrew University Medical Center 2005-2009 Chairman of the Israeli Working Group on Interventional Cardiology, The Israeli Heart Society 4 Name: Morris Mosseri Degree: MD CV: updated 1.2.2012 D. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS 17/5/1995 Co-director of an Israeli Meeting: The Diabetic Heart, Jerusalem, Israel. 24-27/6/2002 Member of Organizing Committee and Chairperson of a Session: Insights from basic science: What does the future look like? The 3rd International Meeting on Intensive Cardiac Care, Tel-Aviv, Israel. 3-4/4/2003 Director of post graduate courses: "Modern Trends un Invasive Cardiology", Sofia and Plovdiv, Bulgaria 30/4-1/5 2003 Chairperson of a session: “Interventional Cardiology”. The 50th Annual Meeting of the Israel Heart Society. Tel-Aviv, Israel. 19-22/10/2003 Co-Chair of a plenary session: Drug-eluting stents and brachytherapy, where do we stand? The 5th International Congress on Coronary Artery disease - From Prevention to Intervention. Florence, Italy. 7-9/12/2003 Co-Chair of a plenary session. The 5th International Meeting on Interventional Cardiology: Frontiers in Interventional Cardiology. Tel-Aviv, Israel. 7-9/12/2003 Moderator at a Plenary Session. Clinical management beyond the cath lab. The 5th International Meeting on Interventional Cardiology: Frontiers in Interventional Cardiology. Tel- Aviv, Israel. 21/4/2004 Co-Chair of a session: Cardiovascular Medicine. The 2nd Israel Meeting on Geriatric Medicine. Tel-Aviv, Israel. 28-29/4/2004 Co-Chair of a session: Myocardial Injury and Repair. The 51st Annual Meeting of the Israel Heart Society. Tel-Aviv, Israel. 6-7/12/2004 Member of the Program Committee and Local Advisory Committee, and Chair of sessions: I.Percutaneous Valvular Interventions. II. Case transmissions (Columbia Medical Center NY). The 6th International Meeting on Interventional Cardiology. Tel-Aviv, Israel. 29/10-1/11/2005 Co-Chair of a session: Acute Coronary Syndromes, Acute Myocardial Infarction. 6th International Congress on Coronary Artery Disease: From Prevention to Intervention. Istanbul, Turkey. 12-14/1/2006 Co-chair of the Annual Meeting of the Working Group on Interventional Cardiology. Haifa, Israel. 3/3/2006 Co-chair of a Meeting of the Israeli Working Groups on Interventional Cardiology and Intensive Cardiac Care Unit. PCI in acute MI. Tel-Aviv, Israel. 5 Name: Morris Mosseri Degree: MD CV: updated 1.2.2012 23/3/2006 Co-Chair of a session: Cardiovascular Interventions. The 1st Israeli Workshop on Transradial Coronary Intervention. Jerusalem, Israel. 26-27/4/2006 Co-Chair of a session: Interventional Cardiology – Primary PCI in Acute MI. The 53rd Annual Meeting of the Israel Heart Society. Tel-Aviv, Israel. 14-18/5/2006 Member of Local Organizing Committee. The 19th International Congress on Thrombosis. Tel-Aviv, Israel. 16-19/5/2006 Chairperson of Case Review session: Urgent Valvular Interventions. The EuroPCR meeting. Paris, France. 26-29/10/2006 Member of the International Scientific Committee. The 1st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy). Berlin, Germany. 3-5/12/2006 Member of the Program Committee and Local Advisory Committee. ICI - Innovations in Cardiovascular Interventions Meeting. Tel-Aviv, Israel. 5/12/2006 Co-Chair of a session: Endovascular and Carotid Innovations. ICI - Innovations in Cardiovascular Interventions Meeting. Tel-Aviv, Israel. 18-19/4/2007 Co-Chair of a session: Interventional Cardiology. The 54th Annual Meeting of the Israel Heart Society. Tel- Aviv, Israel. 22-25/5/2007 Chairperson of Case Review session: PCI dilemmas and controversies in STEMI. The EuroPCR meeting. Barcelona, Spain. 5-7/7/2007 Co-chair of a Meeting of the Working Group on Interventional Cardiology. Interventional Cardiology in Diabetic Patients. Eilat, Israel. 5-7/7/2007 Co-chair of the Annual Meeting of the Working Group on Interventional Cardiology: Interventional Cardiology in DM patients. Eilat, Israel. 7-10/10/2007 Co-chair of a session: New Frontiers in Interventional and Surgical Revascularization. 7th International Congress on Coronary Artery Disease; From Prevention to Intervention. Venice, Italy. 14-16/10/2007 Member of the Local Faculty and Organizing Committee of the 5th International Meeting on Intensive Cardiac Care. Tel Aviv, Israel. 14-16/10/2007 Co Chair of session: PCI and beyond for acute MI. 5th International Meeting on Intensive Cardiac Care. Tel Aviv, Israel. 20-25/10/2007 Discussant. Session III: The Elderly Patient. Roundtable Discussion: New Choices for Old Patients? TCT 2007. Washington DC, U.S.A.. 20-25/10/2007 Discussant. Interventional Strategies and Adjunct Pharmacology in ACS and AMI STEMI. Session VII: The Open Artery Hypothesis and Other Controversies. Moderated Discussion and Audience Q & A. TCT 2007. Washington DC, U.S.A. 6 Name: Morris Mosseri Degree: MD CV: updated 1.2.2012 20-25/10/2007 Live Case Discussant. Structural Heart Disease
Load more

Recommended publications
  • Around the Globe Israeli Medical Association No
    Around The Globe Israeli Medical Association No. 16 | June 2011 A word from the chairman Dear Friends, vices to those from evacuated areas who and opinions on professional issues as e are happy to present you had no access to medical care. well as on the unbalanced exposures and with another issue of ‘IMA I had the pleasure of travelling to discussions of political topics concerning around the Globe’ where the UK, and met our Jewish Medical As- Israel in the British scientific Journals. I Wyou can read about the work of the IMA sociation - UK Chapter. I met medical would like to thank the IMA UK Chapter in Israel and abroad. In February, the students affiliated with the IMA and re- for their generous hospitality during my IMA publically announced our launch viewed Neuroscience practice in Israel. time in London. of “a mission to save public medicine,” I attended an evening event hosted by I am excited to inform you that we demanding additional manpower, more Dr. David Katz, the executive chairman have been invited to present Israeli and beds in hospitals, and incentive pay to of the UK Chapter, which was attended Jewish Medicine at the European Par- draw more physicians to the periphery by the local IMA-WF committee group. liament this November. I would like to and to multiple specialties suffering Throughout the evening we discussed thank Dr. Willie Lipschutz, the executive from physician shortages. This struggle issues related to how Israeli medicine chairman of the Belgian Chapter of IMA- is for health and medicine in Israel and is portrayed in British medical journals, WF for organizing the event.
    [Show full text]
  • Spotted Fever Group Rickettsioses in Israel, 2010–2019
    Spotted Fever Group Rickettsioses in Israel, 2010–2019 Regev Cohen, Talya Finn, Frida Babushkin, Yael Paran, Ronen Ben Ami, Alaa Atamna, Sharon Reisfeld, Gabriel Weber, Neta Petersiel, Hiba Zayyad, Eyal Leshem, Miriam Weinberger, Yasmin Maor, Nicola Makhoul, Lior Nesher, Galia Zaide, Dar Klein, Adi Beth-Din, Yafi t Atiya-Nasagi ≈ In a multicenter, nationwide, retrospective study of pa- SFGRs are associated with 20 species of Rickettsia, tients hospitalized with spotted fever group rickettsiosis of which 16 are considered human pathogens (1,2). in Israel during 2010–2019, we identifi ed 42 cases, of Recent introduction of molecular methods provided which 36 were autochthonous. The most prevalent spe- more information about SFGR agents causing human cies was the Rickettsia conorii Israeli tick typhus strain (n disease and enabled their identifi cation, for which = 33, 79%); infection with this species necessitated inten- the clinical signifi cance of some remains lacking (3). sive care for 52% of patients and was associated with a R. conorii complex, the etiologic agent of Mediterra- 30% fatality rate. A history of tick bite was rare, found for nean spotted fever, includes 4 strains: R. conorii Mal- only 5% of patients; eschar was found in 12%; and leuko- ish (cause of Mediterranean spotted fever), R. conorii cytosis was more common than leukopenia. Most (72%) Astrakhan (cause of Astrakhan fever), R. conorii In- patients resided along the Mediterranean shoreline. For 3 dian tick typhus (cause of Indian tick typhus), and R. patients, a new Rickettsia variant was identifi ed and had been acquired in eastern, mountainous parts of Israel.
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • APF Newsletter, Winter 2006 – 2007
    Winter 2006-2007 APF A Newsletter of the From The President AmericanEmergency Physicians andFellowship Disaster Preparednessfor Medicine in Israel Course News in Israel From The President Israel in Crisis Mission August 2006 would like to share with our members and donors the important by Dr. Dan Moskowitz I APF activities of the past 6 months. his past August, I had the privilege of being invited to par- 1. APF ISRAEL CRISIS FUND REPORT After placing on our T ticipate in an Emergency APF Mission to Israel with APF website and sending a special crisis appeal from Dr. Danny Laor, Board members Drs. Mike Frogel, Paul Liebman and Charles the Deputy Minister for Emergency Preparedness, on the critical Kurtzer. Dr. Boaz Tadmor organized an incredible, whirlwind needs of the Northern hospitals, it was very gratifying indeed that over $100,000 tour for us, only two days after the cessation of hostilities in was received for our Crisis Fund. All of this will be distributed to hospitals such as Israel. We were provided with a unique glimpse of the Israeli Sieff Hospital in Safed, Poriya in Tiberias, Western Galilee Medical Center in Nahariya, and Rambam Medical Center in Haifa, with the hospital CEO’s given the healthcare system under stress, including face-to-face meet- discretion as to how best to utilize these funds to help their hospital in light of the ings with top healthcare officials, as well as visits to the trau- recent crisis. matized hospitals in northern Israel. Perhaps most importantly, we visited 2. MISSION TO ISRAEL Three APF Board members, Drs.
    [Show full text]
  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
    BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay-per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 26, 2021 by guest. Protected copyright. BMJ Open BMJ Open: first published as 10.1136/bmjopen-2020-040210 on 8 February 2021. Downloaded from PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PeterPen) ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2020-040210 Article Type: Protocol Date Submitted
    [Show full text]
  • P2463 Antibiotic Treatment for Invasive Listeriosis and Patient
    P2463 Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein*1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav5,3, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami9,3, Miriam Weinberger10,3, Galia Rahav11,3, Yasmin Maor12,3, Michal Chowers13,3, Ran Nir-Paz2, Mical Paul8,14 1 Rambam Healthcare Campus, Haifa, Israel, 2 Hadassah University Hospital - Ein Kerem, Jerusalem, Israel, 3 Tel Aviv University, Sackler Faculty of Medicine, Ramat Aviv, Israel, 4 Soroka Medical Center, Beersheba, Israel, 5 Rabin Medical Center, Petah Tikva, Israel, 6 Shaare Zedek, Jerusalem, Israel, 7 Laniado Hospital, Netanya, Israel, 8 Technion, The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel, 9 Tel Aviv Sourasky Medical Center , Tel Aviv, Israel, 10 Assaf Harofeh Medical Center, Be’er Ya’akov, Israel, 11 Sheba Medical Center, Ramat Gan, Israel, 12 Wolfson Medical Center, Holon, Israel, 13 Meir Medical Center, Kefar Sava, Israel, 14 Infectious Diseases Unit, Rambam Health Care Campus, Haifa, Israel Background: Current recommendations for treatment of invasive listeriosis suggest ampicillin-based therapy with the addition of an aminoglycoside. However, several reports have suggested higher morbidity and mortality with this regimen as compared with beta-lactam monotherapy. We aimed to evaluate the association between penicillin-aminoglycoside combination therapy and mortality in patients with invasive listeriosis while adjusting for timing of treatment onset. Materials/methods: This is a multicenter retrospective observational study of adult patients with invasive listeriosis (primary bacteremia, central nervous system [CNS] disease and pregnancy-associated listeriosis) in 11 hospitals in Israel between the years 2008-2014. We evaluated the effect of penicillin-based monotherapy compared with early combination therapy with gentamicin, defined as treatment started within 48 hours of culture results and continued for a minimum duration of 7 days.
    [Show full text]
  • General Hospital Beds in Israel
    Overview Date: 13 Kislev 5780, 11 December 2019 Written by: Aharon Blank, Flora Koch Davidovich | Approved by: Shelly Levy, Team Leader General hospital beds in Israel There are 45 general hospitals in Israel, a quarter of which are government-owned (nine government hospitals and two government–municipal hospitals).1 A general hospital is comprised of the following wards: internal medicine, intensive care, pediatrics, surgery, maternity wards, and intermediate care wards. Israel has a shortage of beds in general hospitals; for many years, various parties—including the State Comptroller—have noted the gap between the demands made of the system of general hospitals and the resources allocated to it, and they have called for long-term planning of the system of general hospitals in Israel.2 According to data from the Ministry of Health, in January 2019 there were 16,021 acute care beds in Israel—15,871 in general hospitals and 151 in geriatric hospitals. The rate of acute care beds in Israel has been declining since the late 1970s; as of 2019, it stands at 1.78 beds per 1,000 people, as compared to 1.88 in 2011 and 2.09 in 2005.3 Ministry of Health data from January 2019 on the geographic distribution of acute care beds indicates that nearly half are located in the central district (23.8%) and Tel Aviv (21.4%), while the remaining beds are in the Haifa district (15.2%), Jerusalem (14.5%), the northern district (12.7%) and the southern district (12.3%).4 A comparison of the rate of acute care beds in hospitals per 1,000 people in Israel to the rate in 34 OECD member states, based on data from 2017,5 indicates a decline in the rate of acute care beds in hospitals in OECD countries due to technological developments and the expansion of community healthcare services, among other things.
    [Show full text]
  • Hadassah Year in Review 2019 LR
    YEAR IN REVIEW 2019 Hadassah International was established in 1983 by Hadassah, the Women’s Zionist Organization of America at the initiative of Past National President Bernice S. Tannenbaum, in order to unite people of all faiths and nationalities in their mission to improve lives around the globe through their financial support of the pioneering medical healing, teaching, and research at the Hadassah Medical Organization in Jerusalem. Hadassah International spans five continents and is made up of volunteer men and women who believe that advancement and cooperation in medicine transcend politics, religion and national boundaries. The universal language of medicine allows Hadassah International to build bridges between nations and Every day let us remind help to establish research and clinical ventures between ourselves that there are the Hadassah Medical Organization and medical always new worlds to institutions around the world. conquer, new barricades to jump over. The next Hadassah Medical Organization, founded by Hadassah, decades are on the horizon the Women’s Zionist Organization of America, and let us be ready for them and may it be in a established modern healthcare in Israel. world of shalom (peace).” Bernice S. Tannenbaum Founder, Hadassah International (Pictured on Cover): Esther Tafara is chief technological engineer of the new Mount Scopus catheterization lab. A true story of bravery, the young Tafara came to Israel all alone at the age of nine as her parents and siblings were not allowed to leave Ethiopia. From the airport, she took a taxi in search of distant relatives in Jerusalem. From those shaky beginnings, Tafara went on to pursue studies in medical engineering and worked at the pulmonary department in Ein Kerem.
    [Show full text]
  • Israeli Cardio-Oncology Society Virtual Meeting Preliminary Program
    January 13-14, 2021 | Virtual Conference TOWARDS A COMPREHENSIVE CARDIAC-CANCER CARE Take this unique opportunity to join the ISCO 2021 conference and to effectively reach hundreds of cardiologists, oncologists and hemato-oncologists. Join us and present your research and technology to this influential and knowledgeable audience, and to have full access to all networking benefits. Conference secretariat - Dirigo Events & Conferences 3 Menorat Hamaor st. Tel-Aviv, Israel For more information, please contact: Tel: 03-7775485 | Email: [email protected] Yael Ziv Project Manager – Industry Liaison, Dirigo | Mobile: +972-54-5599821 | Email: [email protected] ISRAELI CARDIO-ONCOLOGY SOCIETY VIRTUAL MEETING PRELIMINARY PROGRAM Platinum Sponsorship Gold Sponsorship Silver Sponsorship January 13, 2021 15:45-16:00 Opening Session 15:45-15:47 Zaza Iakobishvili, Founder and Chair of the Meeting, Cardiology 15:47-15:49 Dan Gilon, Chair of the Meeting, Cardiology 15:49-15:51 David Sarid, Chair of the Meeting, Oncology 15:51-15:53 Martin Ellis, Chair of the Meeting, Hematology 15:53-15:55 Alex Lyon, ESC Cardio-Oncology Council 15:55-15:57 Bonnie Ky, JACC Cardio-Oncology 16:00-17:00 Plenary Session Chairs: Giorgio Minnotti, Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, Italy Alexander Battler, Chairman, Advisory Council on Cardiovascular Disease Management and Prevention, Ministry of Health, Israel 16:00-16:20 How to establish Cardio-Oncology collaboration Susan F. Dent, Associate Director of Breast Cancer Clinical Research, Co-Director Duke Cardio-Oncology Program, Durham, NC, USA 16:20-16:40 Guidelines in Cardio-Oncology: Gaps and Opportunities José Luis Zamorano, University Hospital Ramon Y Cajal, Madrid, Spain 16:40-17:00 Panel discussion: Future of Cardio-Oncology Richard H.
    [Show full text]
  • 15 July, 2021 to the Honourable: Prime Minister Naftali
    15 July, 2021 To the Honourable: Prime Minister Naftali Bennett Re: Severe Warning – A Lockdown During The Upcoming Holidays Will be Catastrophic Urgent Request for a Meeting with the Prime Minister To the Honourable Prime Minister, Firstly, we wish to congratulate you on the formation of the new government. The complexity of the task you have taken on is unparalleled, certainly in these challenging times, and we wish you heartfelt success. We are hearing warnings of an impending lockdown during the upcoming holiday period, and we would like to state clearly and strongly - another lockdown will be nothing short of a catastrophe. The Public Emergency Council is a spontaneous initiative of doctors and researchers who felt that it was no longer possible to remain silent in the face of the outgoing government's steps to contain the COVID- 19 pandemic. As you can see below, among the members of the Council are individuals who constituted and still constitute the backbone of the medical establishment in this country, individuals who are at the heart of the medical consensus: four Israel Prize laureates, a Nobel laureate, experts who have managed four hospitals, a former Director General of the Ministry of Health, a HMO Director General, an IDF Deputy Chief Medical Officer, a founding member of Israel’s epidemic treatment team and an expert in disaster situations, university department heads, deans and deputy deans of medical faculties, all of whom have joined together in an extraordinary step, without any political, commercial or personal interest, in order to contribute the vast knowledge and experience which they have acquired to the relevant decision makers.
    [Show full text]
  • Curriculum Vitae Dr. Toren Orly. RN, BSN, Msc, Phd 1. Personal Details
    June 2019 1 Curriculum Vitae Dr. Toren Orly. RN, BSN, MSc, PhD 1. Personal Details Date of Birth: 4.7.1959 Country of birth: Israel Citizenship – Israel Number of children – 2 Military service – IDF: 1977-1979 Business address: Hadassah Medical Organization, Jerusalem, 91120 Tel: business: 02 – 6777245 Fax: 02 - 6778256 Email: [email protected] 2. Higher Education a. Academic Education 1979-1983 – Hebrew University, Jerusalem, Nursing, RN, and Bachelor in Nursing (BSN), with honors. 1985-1986 – Tel-Aviv University, Faculty of Social Sciences. Studies toward Master Degree in social sciences. 1987-1991 – Tel-Aviv University, Faculty of Business Administration. Master of Management Science (MSc.), with honors. 1995-1998 – Pittsburgh University, School of Nursing , Pittsburgh, PA, USA , Doctor of Philosophy (PhD.), with honors. Title of Master’s thesis - Relationship between job pressures and a person’s unfitness to the environment, and organizational commitment. Supervisor’s name – Prof. Mina Westman. 2 Title of Doctoral Dissertation - Mental and physical health of heart recipients as predictors of the spouse-caregivers' health one year after the transplant. Supervisor’s name – Prof. Jacqueline Dunbar-Jacob b. Advanced Academic Certification 1984 – Advanced course in Intensive Care, Sheba Academic Nursing School. 1996 – Mediation Course for medical professions, Gome, The Israeli Center for Medication practices 2008 - Good Clinical Practice in Research Certification, Hadassah Medical Organization and Hebrew University 2009 – Couching for Life, The Israeli Center for Management, Ramat Gan. 2015 – Risk Management, Technion. 2017 - Expertise in Nursing Policy and Management, Ministry of health, Profession Founder c. Clinical Practice Licensure, Registration, Certification (all active) Registered Nursing License, Hebrew University Licensed Specialty in ICU Nursing, Ministry of Health, Israel Expert in Nursing Policy and Management, Ministry of health 3.
    [Show full text]